🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The POMPEII Registry offers detailed pharmacodynamic data on cangrelor in patients with acute and chronic coronary syndromes undergoing PCI. Cangrelor provided moderate platelet inhibition, with low rates of high residual platelet reactivity (HRPR) during infusion. However, HRPR

This comprehensive review by Goel et al. explores the principles, procedural details, and outcomes of techniques including BASILICA, ShortCut, UNICORN, and newer methods like CATHEDRAL and Splitter. Each approach is discussed in the context of anatomical challenges, device

Nightmare in TAVI : how to prevent device migration, protect the aorta during retrieval, and optimise valve positioning in narrow SOV anatomies. 🔗pcronline.com/Cases-resource… Watch now to sharpen your approach to challenging valve cases. #TAVI #TAVR #interventionalcardiology

NEW ISSUE OUT! 📌 New LAAC implanter classification system; 📌 Measuring PCAT attenuation; 📌 5-year follow-up of the SORT OUT VIII, IX and IDEAL-LM trials; 📌 Catheter-directed thrombolysis vs anticoagulation in PE; and much more #EAPCI ow.ly/Wll350W2kLw

🔥The European LAAC Club proposes a novel LAAC implanter classification system integrating anatomical and functional criteria. Aiming to support preprocedural planning, training, and risk stratification in #LAAclosure. Jens Erik Nielsen-Kudsk Dr Philippe Garot #EAPCI #InterventionalCardiology

Test your knowledge: seeking light in the shadow of complications. 🔗pcronline.com/Cases-resource… What do you see in this image submitted by Maciej Lesiak and a team from 🇵🇱 and selected for #EuroPCR? #interventionalcardiology

PCAT attenuation on coronary CT angiography is a novel marker of coronary inflammation and is independently linked to worse outcomes after stenting. Including PCAT attenuation with traditional risk factors improves risk prediction and may help identify patients who could benefit

5-year data from SORT OUT VIII: SYNERGY EES and BioMatrix BES stents had similar TLF rates, but SYNERGY showed lower MI incidence (6.1% vs 8.4%). Thin struts + fast polymer degradation may enhance long-term safety. #InterventionalCardiology #DES #CardioTwitter

IDEAL-LM 5-year results: In patients undergoing PCI for left main disease, biodegradable-polymer DES + 4mo DAPT showed no advantage over durable-polymer DES + 12mo DAPT. MACE, MI, TVR, and ST rates were similar. #EAPCI #LMPCI #DES #DAPT ow.ly/W1QI50W4OXj

🎥Davide Capodanno shares how his role as Editor-in-Chief at EuroIntervention allows him to give back to the cardiology community. Thank you for this interview TCTMD!

A new Editorial to read on EIJ 👉 "Using pericoronary fat attenuation to guide management after coronary interventions" Charalambos Antoniades #EAPCI ow.ly/vR5450W5op4 Original Article by Naniwa S. et al: eurointervention.pcronline.com/article/impact…

Coronary inflammation on #CCTA offers prognostic value beyond plaque burden in #PCI patients. Residual inflammatory risk may guide long-term therapy decisions, including statin use and anti-inflammatory strategies. #InterventionalCardiology #EAPCI ow.ly/kTAj50W5op5

PRAGUE-26, a prospective, academic RCT comparing outcomes of catheter-directed thrombolysis vs. anticoagulation in intermediate-high risk PE. Designed to assess efficacy, safety, and cost-effectiveness over 2 years. #PulmonaryEmbolism #EAPCI ow.ly/g2ZN50W6gYY

COMPARE STEMI ONE is the first RCT to assess 1-month DAPT followed by prasugrel monotherapy in STEMI patients. Also evaluated OCT-guided vs. angiography-guided staged PCI for non-culprit lesions. Protocol published 👇eurointervention.pcronline.com/article/prasug… #DAPT #STEMI #OCT #PCI #rctst

This study showed that the SAPIEN 3 Ultra RESILIA (S3UR) valve offers significantly better performance for #TAVR in severe aortic stenosis compared to the SAPIEN 3 valve. The S3UR valve reduces paravalvular leakage (PVL) and patient-prosthesis mismatch (PPM), especially in

This editorial discussed the evolving role of ticagrelor monotherapy in chronic coronary syndrome (CCS) after PCI, following a TWILIGHT subgroup analysis. While findings suggest feasibility in high ischaemic risk patients, the authors caution that comparative data vs. clopidogrel

CT-based thrombus attenuation is independently associated with HALT resolution after #TAVI. Prosthesis deformation parameters (eccentricity, canting) also impact #HALT evolution. Imaging may support risk stratification and guide management. ow.ly/tZXb50VSacI #EAPCI

AMAC: Anchor the Mother to Advance the Child – A technique for complex PCI faced with a tough RCA CTO and multiple failed attempts, the AMAC technique changed the game. Anchoring the system gave the support needed to cross and treat the lesion—no stent, no compromise. A smart

🆕 Out now: the latest issue of EuroIntervention Featuring: • Antithrombotics in women with ACS • QFR guideline debate • Short DAPT in diabetes + HBR • TAVI for AR • Chimney stenting in redo-TAVI • Early discharge after TAVI 🔗eurointervention.pcronline.com/issue/volume-2… #CardioTwitter #TAVI

🆕 EAPCI/ESC consensus on antithrombotic therapy in women with #ACS now published. Highlights sex-specific bleeding risks, under-representation in trials, and tailored approaches to #DAPT, MINOCA, and SCAD. 🔗 ow.ly/YH0L50WanBY #WomenInCardiology #InterventionalCardiology